Home / Equities / Equities Analysts Set Expectations for Karyopharm Therapeutics Inc.’s FY2021 Earnings (NASDAQ:KPTI)

Equities Analysts Set Expectations for Karyopharm Therapeutics Inc.’s FY2021 Earnings (NASDAQ:KPTI)

Equities researchers at Wedbush dropped their FY2021 earnings estimates for shares of Karyopharm Therapeutics in a note issued to investors on Monday, January 10th. Wedbush analyst D. Nierengarten now …
Read Full Story at source (may require registration)